16, 2013 2013 ACCF/AHA Heart Failure Guidelines: Executive Summary October 15, 2013:1495 539 Appendix 1. Author Relationships With Industry and Other Entities (Relevant)d2013 ACCF/AHA Guideline for the Management of Heart Failure Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* Clyde W. Yancy, Chair Northwestern UniversitydChief, Division of Cardiology and Magerstadt Professor of Medicine None None None None None None None Mariell Jessup, Vice Chair University of PennsylvaniadProfessor of Medicine None None None  Amgen  Celladon  HeartWare None None 7.4.4 Biykem Bozkurt Michael E. DeBakey VA Medical CenterdThe Mary and Gordon Cain Chair and Professor of Medicine None None None None None None None Javed Butler Emory HealthcaredDirector of Heart Failure Research; Emory University School of MedicinedProfessor of Medicine  Amgen  CardioMEMS  Gambro  Takeda None None None  Amgen  Biotronic  Boston Scientific  CardioMEMS  Cortheray  FoldRx  iOcopsys  Johnson & Johnson  Medtronic  Thoratec  World Heart Donald E. Casey, Jr Clinically Integrated Physician Network, NYU Langone Medical CenterdVice President and Medical Director None None None None None None None Mark H. Drazner University of Texas Southwestern Medical CenterdProfessor, Internal Medicine None None None  HeartWare  Scios/Johnson & Johnsony  Medtronic  Thoratecy Gregg C. Fonarow Director AhmansondUCLA Cardiomyopathy Center; Co-ChiefdUCLA Division of Cardiology  Gambro (formerly CHF Solutions)  Medtronic  Novartisy  Takeda None None  Gambro (formerly CHF Solutions)  Novartisy  Medtronic None 7.1 7.2 (Class IIa) Stephen A. Geraci Quillen College of Medicine/East Tennessee State Universityd Chairman of Internal Medicine None None None None None None None (Continued on the next page) JACC Vol. 62, No. 16, 2013 Yancy et al. 